Annexon Presents at J.P. Morgan Healthcare Conference, Discloses New Clinical Programs

Annexon, Inc. is presenting at the 44th annual J.P. Morgan Healthcare Conference, discussing its efforts to stop neuroinflammation at its source. The company's forward-looking statements include potential therapeutic benefits of its product candidates, clinical and preclinical programs, and the timing of future nonclinical studies and clinical trials.